Northwestern Mutual Wealth Management Co. Has $25.07 Million Stock Holdings in Centene Co. (NYSE:CNC)

Northwestern Mutual Wealth Management Co. boosted its position in shares of Centene Co. (NYSE:CNC) by 0.7% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 378,149 shares of the company’s stock after purchasing an additional 2,565 shares during the quarter. Northwestern Mutual Wealth Management Co. owned 0.07% of Centene worth $25,071,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of CNC. Pinebridge Investments L.P. lifted its holdings in Centene by 52.4% during the fourth quarter. Pinebridge Investments L.P. now owns 327,442 shares of the company’s stock worth $24,298,000 after acquiring an additional 112,605 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Centene by 18.7% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 624,944 shares of the company’s stock valued at $49,046,000 after buying an additional 98,298 shares in the last quarter. GSA Capital Partners LLP boosted its holdings in shares of Centene by 435.0% in the first quarter. GSA Capital Partners LLP now owns 20,052 shares of the company’s stock valued at $1,574,000 after buying an additional 16,304 shares during the period. Diversified Trust Co raised its holdings in shares of Centene by 35.8% during the second quarter. Diversified Trust Co now owns 28,009 shares of the company’s stock worth $1,857,000 after acquiring an additional 7,385 shares during the period. Finally, Bessemer Group Inc. boosted its stake in Centene by 189.6% in the 1st quarter. Bessemer Group Inc. now owns 24,162 shares of the company’s stock worth $1,895,000 after purchasing an additional 15,819 shares during the period. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Trading Up 0.9 %

CNC stock opened at $75.27 on Tuesday. The stock has a market cap of $40.17 billion, a price-to-earnings ratio of 14.96, a price-to-earnings-growth ratio of 1.02 and a beta of 0.48. The company has a fifty day moving average price of $75.41 and a two-hundred day moving average price of $73.33. Centene Co. has a one year low of $63.45 and a one year high of $81.42. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.17 and a quick ratio of 1.17.

Centene (NYSE:CNC) last announced its quarterly earnings results on Friday, July 26th. The company reported $2.42 EPS for the quarter, missing analysts’ consensus estimates of $2.44 by ($0.02). The company had revenue of $39.84 billion during the quarter, compared to analyst estimates of $36.83 billion. Centene had a net margin of 1.79% and a return on equity of 14.45%. The firm’s quarterly revenue was up 5.9% on a year-over-year basis. During the same quarter last year, the company posted $2.10 EPS. Equities analysts anticipate that Centene Co. will post 6.8 EPS for the current year.

Analyst Ratings Changes

A number of analysts have recently commented on CNC shares. Truist Financial cut their price target on Centene from $92.00 to $89.00 and set a “buy” rating on the stock in a report on Monday, July 15th. StockNews.com upgraded shares of Centene from a “buy” rating to a “strong-buy” rating in a report on Monday, July 29th. Barclays reduced their target price on shares of Centene from $98.00 to $97.00 and set an “overweight” rating for the company in a report on Thursday, September 5th. Wells Fargo & Company cut their price target on shares of Centene from $93.00 to $91.00 and set an “overweight” rating on the stock in a research report on Friday, September 13th. Finally, TD Cowen raised their price objective on Centene from $80.00 to $89.00 and gave the company a “buy” rating in a report on Wednesday, July 31st. Seven investment analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Centene presently has an average rating of “Moderate Buy” and an average price target of $85.58.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.